Loading clinical trials...
Loading clinical trials...
Adherence of Patients Using Travalert® for Instillation of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Compared to a Concomitant Regimen of Travoprost 0.004% and Timolol 0.5%
Conditions
Interventions
Travoprost 0.004%/timolol 0.5% fixed combination eye drops (DuoTrav)
Travoprost 0.004% eye drops
+2 more
Locations
1
Spain
Zaragoza
Zaragoza, Spain
Start Date
October 1, 2007
Primary Completion Date
January 1, 2010
Completion Date
January 1, 2010
Last Updated
July 12, 2012
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
NCT06689696
Lead Sponsor
Alcon Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions